Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Pfizer Inc (PFE)
Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 162,503,776
  • Shares Outstanding, K 5,646,413
  • Annual Sales, $ 100,330 M
  • Annual Income, $ 31,372 M
  • 60-Month Beta 0.61
  • Price/Sales 1.61
  • Price/Cash Flow 3.82
  • Price/Book 1.69
Trade PFE with:

Options Overview Details

View History
  • Implied Volatility 23.85% ( -1.08%)
  • Historical Volatility 27.51%
  • IV Percentile 55%
  • IV Rank 35.38%
  • IV High 33.73% on 10/27/23
  • IV Low 18.44% on 06/09/23
  • Put/Call Vol Ratio 0.91
  • Today's Volume 104,626
  • Volume Avg (30-Day) 154,219
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 2,361,925
  • Open Int (30-Day) 2,136,612

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.16
  • Number of Estimates 6
  • High Estimate -0.10
  • Low Estimate -0.22
  • Prior Year 1.14
  • Growth Rate Est. (year over year) -114.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.30 +1.70%
on 12/01/23
30.75 -6.41%
on 11/27/23
-2.04 (-6.62%)
since 11/08/23
3-Month
28.30 +1.70%
on 12/01/23
34.62 -16.87%
on 09/13/23
-5.47 (-15.97%)
since 09/08/23
52-Week
28.30 +1.70%
on 12/01/23
54.93 -47.61%
on 12/14/22
-23.00 (-44.42%)
since 12/08/22

Most Recent Stories

More News
Gene Therapy Breakthrough: Two Treatments Approved by FDA for Sickle Cell Disease

The U.S. Food and Drug Administration (FDA) has taken a groundbreaking step by approving two gene therapies for sickle cell disease, marking a significant advancement in the treatment of this debilitating...

PFE : 28.78 (+0.52%)
BLUE : 2.86 (-40.54%)
CRSP : 64.54 (-8.08%)
VRTX : 350.15 (-1.07%)
Pfizer's Latest Ozempic Competitor Just Flopped (Again). Is the Stock Still a Buy?

It's already planning to get back on the horse and make another attempt.

LLY : 598.05 (+1.66%)
JPM : 158.52 (+1.10%)
PFE : 28.78 (+0.52%)
Pfizer Inc. (PFE) vs. Taro Pharmaceutical (TARO) - Betting on Which Pharma Stock Will Have Q4 Dominance

The pharmaceutical industry’s prospects are driven by the rising occurrence of chronic diseases coupled with the adoption of cutting-edge technology. In this context, which company among the two major...

PFE : 28.78 (+0.52%)
TARO : 37.89 (+2.41%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

AVRN : 0.0125 (-30.56%)
ONCY : 1.4000 (unch)
ONC.TO : 1.90 (-0.52%)
PFE : 28.78 (+0.52%)
ARVN : 34.16 (+4.50%)
OLMA : 12.13 (+4.03%)
AZN : 63.25 (-0.41%)
Looking for Dividend Growth in the New Year? 3 Magnificent Stocks to Buy Now.

These particular players look cheap right now.

ABT : 104.51 (+0.44%)
ABBV : 149.28 (+0.89%)
MDT : 79.35 (-0.25%)
PFE : 28.78 (+0.52%)
How to Buy PFE For a 7% Discount, or Achieve a 16% Annual Return

Selling cash secured puts on stocks an investor is happy to take ownership of is a great way to generate some extra income.

PFE : 28.78 (+0.52%)
LITFULO™ Receives Health Canada Approval, Becoming the First Approved Treatment for Severe Alopecia Areata in Canada.

/CNW/ - Today, Pfizer Canada announced that Health Canada has granted a Notice of Compliance (NOC) for LITFULO™ (ritlecitinib). A once-daily oral treatment,...

PFE : 28.78 (+0.52%)
Roche's Bold Move into Obesity Treatment with $2.7B Carmot Therapeutics Takeover

Swiss pharmaceutical giant Roche (ROG) has marked a significant strategic shift by acquiring Carmot Therapeutics (CRMO), an obesity drug developer, for an upfront payment of $2.7 billion. This move positions...

ROG : 130.07 (+1.86%)
LLY : 598.05 (+1.66%)
AZN : 63.25 (-0.41%)
PFE : 28.78 (+0.52%)
ROIV : 9.83 (+0.82%)
Is Pfizer Stock a Buy Now?

Pfizer shares have fallen by double digits this year.

PFE : 28.78 (+0.52%)
Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes

For growth investors, it may be time to sell this pharma stock for tax-loss harvesting purposes.

PFE : 28.78 (+0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 29.34
2nd Resistance Point 29.15
1st Resistance Point 28.97
Last Price 28.78
1st Support Level 28.59
2nd Support Level 28.40
3rd Support Level 28.22

See More

52-Week High 54.93
Fibonacci 61.8% 44.76
Fibonacci 50% 41.61
Fibonacci 38.2% 38.47
Last Price 28.78
52-Week Low 28.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar